NTLA SG&A Expenses

Intellia Therapeutics Inc · SG&A Expenses

NTLA logo

NTLA SG&A Expenses

Latest reported$152.05M
NTLA SG&A Expenses ($3.57M → $152.05M)
High-resolution chart · PNG

NTLA sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Intellia Therapeutics Inc SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
119,800,000
125,829,000
116,497,000
90,306,000
71,096,000
44,169,000
41,058,000
32,189,000
28,025,000
16,798,000
8,283,000
3,568,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.